Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery
- 1 September 2016
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 134 (3) , 324-328
Abstract
Objective: To compare the effectiveness and safety of carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following cesarean deliveries.Methods: A double‐blind randomized controlled trial enrolled patients with a singleton pregnancy scheduled for an elective cesarean delivery at a maternity hospital in Cairo, Egypt, between October 1, 2012 and June 30, 2013. Participants were randomized using a computer‐generated sequence to receive treatment with carbetocin, misoprostol, or oxytocin. The primary outcome was the occurrence of uterine atony necessitating additional uterotonics. Per‐protocol analyses were performed. Patients, investigators, and data analysts were masked to treatment assignments.Results: The present study enrolled 263 patients; data were analyzed from 88 patients treated with carbetocin, 89 treated with misoprostol, and 86 women treated with oxytocin. Further uterotonics were needed for the treatment of 5 (6%) patients who were treated with carbetocin, 20 (22%) patients treated with misoprostol, and 11 (13%) patients treated with oxytocin. In the prevention of uterine atony, carbetocin was comparable with oxytocin (RR 0.41, 95%CI 0.14–1.25) and superior to misoprostol (RR 0.21, 95%CI 0.07–0.58).Conclusion: Additional uterotonics were needed less frequently by patients treated with carbetocin. Carbetocin was comparable to oxytocin and superior to misoprostol in the prevention of uterine atony following an elective cesarean delivery.ClinicalTrials.gov: NCT02053922Keywords
This publication has 20 references indexed in Scilit:
- Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2013
- Misoprostol for the management of postpartum haemorrhageBMJ, 2011
- Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double‐blind randomised trialBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Prevention of postpartum haemorrhage with the oxytocin analogue carbetocinEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trialArchives of Gynecology and Obstetrics, 2009
- Misoprostol for the prevention and treatment of postpartum haemorrhageBest Practice & Research Clinical Obstetrics & Gynaecology, 2008
- Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in EuropeBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin AmericaThe Lancet, 2006
- Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean sectionInternational Journal of Gynecology & Obstetrics, 2005
- Pharmacology of Oxytocin and ProstaglandinsClinical Obstetrics and Gynecology, 2000